Sign Up Today and Learn More About Endeavor BioMedicines Stock
Invest in or calculate the value of your shares in Endeavor BioMedicines or other pre-IPO companies through EquityZen's platform.
Endeavor BioMedicines Stock (ENBI)
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
About Endeavor BioMedicines Stock
Founded
2018
Headquarters
Solana Beach, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Endeavor BioMedicines Press Mentions
Stay in the know about the latest news on Endeavor BioMedicines
Methods of treating fibrosis
patents • May 04, 2025
Endeavor BioMedicines Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
biospace • May 01, 2025
Endeavor BioMedicines Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
businesswire • May 01, 2025
Eight respiratory disease companies advancing innovative therapies in 2025
labiotech • Mar 01, 2025
Methods of treating fibrosis
patents • Feb 08, 2025
Endeavor BioMedicines Management
Leadership team at Endeavor BioMedicines
Founder and Executive Chairman
John Hood
Co-Founder and Chief Scientific Officer
Miguel de los Rios
Join now and verify your accreditation status to gain access to:
- Endeavor BioMedicines Current Valuation
- Endeavor BioMedicines Stock Price
- Endeavor BioMedicines Management
- Available deals in Endeavor BioMedicines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Endeavor BioMedicines Cap Table and Funding History by Share Class and Liquidity Preferences
- Endeavor BioMedicines Revenue and Financials
- Endeavor BioMedicines Highlights
- Endeavor BioMedicines Business Model
- Endeavor BioMedicines Risk Factors
- Endeavor BioMedicines Research Report from SACRA Research
Trading Endeavor BioMedicines Stock
How to invest in Endeavor BioMedicines stock?
Accredited investors can buy pre-IPO stock in companies like Endeavor BioMedicines through EquityZen funds. These investments are made available by existing Endeavor BioMedicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Endeavor BioMedicines stock?
Shareholders can sell their Endeavor BioMedicines stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
